|

Cyclosporine Clinical Trials

8 actively recruiting trials across 3 locations

▲ +2 trials since May 2026

Also known as: 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A +7 more

Pipeline

Phase 1: 1Phase 2: 5Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Fred Hutchinson Cancer Center5
  • University of Birmingham1
  • University Hospital, Angers1
  • Memorial Sloan Kettering Cancer Center1

Indications

  • Cancer8
  • Acute Lymphoblastic Leukemia6
  • Acute Myeloid Leukemia5
  • Chronic Myelomonocytic Leukemia3
  • Mixed Phenotype Acute Leukemia3

Seattle, Washington4 trials

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Fred Hutch/University of Washington Cancer Consortium

Phase 1/2
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Fred Hutch/University of Washington Cancer Consortium

Phase 1
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutch/University of Washington Cancer Consortium

Phase 2
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Other2 trials

Methods of T Cell Depletion Trial (MoTD)
Phase 2
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
Phase 2/3

Tampa, Florida1 trial

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Moffitt Cancer Center

Phase 2

New York, New York1 trial

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.